Are there any posters with Big Pharma experience? How complicated is the process on BP's end to acquire or partner with a micro-cap biotech like Cytodyn? I would think that this would be very complicated, requiring input from multiple departments, and approval from the C suite.. As investors, we focus on being acquired or partnering, since those are our perceived means of increasing shareholder value. However, it does take two to tango. Some insight to our dance partners might be helpful in understanding what management is experiencing.

An observation: The NP regime used a scatter gun to shoot at any bird that flew across the screen. The JL management team has identified their target birds. They are using a shotgun, but the shot pattern is much narrower with improved efficiency. Here's hoping that the result is one in the hand. The two in the bush have already escaped.